Case Law & Settlements

Cuevas v. Contra Costa County: ACA Coverage Evidence and Future Medical Damages in MICRA Cases

Cuevas held that a MICRA defendant may put evidence of future Affordable Care Act insurance benefits before the jury when it values future…

Pediatric hospital room with medical equipment and soft window light

Cuevas held that a MICRA defendant may put evidence of future Affordable Care Act insurance benefits before the jury when it values future medical care. Here is what the decision says, where it stops, and how plaintiffs respond at trial.

Future medical expenses are often the largest economic component of a catastrophic malpractice verdict, and they are the item defendants work hardest to reduce. In Cuevas v. Contra Costa County (2017) 11 Cal.App.5th 163, the First District Court of Appeal gave medical malpractice defendants a significant tool: the ability to introduce evidence that the plaintiff's future care could be covered by health insurance available under the Affordable Care Act. Nearly a decade later, Cuevas continues to shape how life care plans are built and attacked in California professional negligence cases.

The case

Cuevas was a birth injury case against a county medical center. The child suffered a hypoxic-ischemic brain injury, and the jury awarded substantial damages, including roughly $9.6 million for future medical care. Before trial, the county sought to introduce evidence that the child's future care could be purchased through ACA-compliant insurance and that the cost of such coverage, plus out-of-pocket expenses, would be far less than the billed charges in the plaintiff's life care plan. The trial court excluded that evidence.

On appeal, the court held that the exclusion was error and reversed the future medical damages award, ordering a new trial limited to that issue. The key to the decision is Civil Code section 3333.1, the MICRA provision that modifies the collateral source rule in professional negligence actions against health care providers. Section 3333.1 allows a defendant to introduce evidence of amounts payable to the plaintiff from health insurance and other collateral sources. The court read that provision as applying to future insurance benefits, not only past payments, and concluded that evidence of ACA coverage was relevant to the jury's valuation of future medical care.

Why the holding is narrower than defendants suggest

Cuevas is a MICRA decision. Its reasoning depends on section 3333.1, which applies only to actions for professional negligence against health care providers. Outside that context, the traditional collateral source rule continues to bar evidence that the plaintiff has or may obtain insurance to cover future care. Defense counsel in auto, premises, and product cases sometimes cite Cuevas for a broader proposition about future insurance, and plaintiff counsel should be prepared to confine it to its statutory basis.

Even within MICRA cases, Cuevas did not hold that ACA evidence is conclusive or that future damages must be measured by insurance premiums. It held that the evidence is admissible and that the jury may consider it. The weight of that evidence remains a fact question, and plaintiffs have substantial grounds to challenge it.

How plaintiffs answer ACA evidence at trial

Plaintiff counsel have developed several lines of response since Cuevas.

  • Uncertainty about the future of the ACA. A life care plan for a child with a brain injury projects costs for decades. The ACA's structure, subsidies, and coverage mandates have been the subject of repeated legislative and judicial challenge. Expert testimony on the political and regulatory uncertainty of any particular insurance program over a sixty-year horizon goes directly to the weight of the defense evidence.
  • Network and coverage limitations. ACA plans have provider networks, prior authorization requirements, and coverage exclusions. Many items in a catastrophic life care plan, such as attendant care, home modifications, specialized therapies, and certain equipment, may not be covered or may be covered only in limited amounts. A life care planner should identify which items fall outside typical plan coverage.
  • Access to specialists. Children with complex neurological injuries often need care from specialists and centers that may be out of network. Treating physician testimony about the actual providers the child needs is persuasive here.
  • Premiums, deductibles, and out-of-pocket maximums. If the defense presents insurance as the measure of future costs, the plaintiff is entitled to have the jury consider the full cost of maintaining coverage over the plaintiff's lifetime, including premiums and annual out-of-pocket amounts.

Effects on life care planning

Cuevas changed how plaintiffs prepare future medical damages in MICRA cases. Life care planners increasingly present costs in multiple ways: billed charges, reasonable value, and, where appropriate, analysis of whether specific items would be covered under available insurance. That approach anticipates the defense evidence and lets the plaintiff frame it. The decision also increased the importance of the economist, who must address how insurance-based projections compare with the plaintiff's actual care needs over time.

The decision also interacts with other future-damages tools in MICRA cases, including periodic payment of future damages under Code of Civil Procedure section 667.7, which can be requested where the future damages award meets the statutory threshold. Counsel should model how ACA evidence, periodic payments, and MICRA's noneconomic damages limits affect the total recovery before mediation, not after verdict.

Practice points

In any MICRA case with significant future care, assume the defense will offer ACA evidence. Disclose experts who can address insurance coverage gaps and the long-term uncertainty of the program. Develop treating physician testimony about specific providers and services. Consider a motion in limine to limit the defense presentation to competent expert testimony about actual coverage, rather than generalized assertions that insurance will pay. Our medical malpractice archive covers related MICRA damages issues, and our case law coverage tracks appellate decisions applying section 3333.1. Cuevas gave defendants an argument, not a formula, and the response is evidence about how care is actually delivered and paid for over a lifetime.

Who LawyersTrend is for

Three ways in

Selling to the PI bar? See sponsor and advertiser options.